相关实验视频
Updated: Jul 9, 2025

07:58
Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
8.9K
抗生素诱导的毒性概述
Ruth E Campbell1, Chang Huei Chen1, Charles L Edelstein1
1Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Kidney international reports
|November 29, 2023
概括
抗生素可能会导致损伤 (毒性),导致急性损伤 (AKI). 新的生物标志物可以更早地检测和更好地管理患者的这种情况.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 药物诱导的毒性是急性损伤 (AKI) 的重要原因,在住院患者中占病例的60%左右.
- 抗生素经常与药物诱导的毒性有关,有助于增加发病率和死亡率.
- 已确定的机制包括球体和管状损伤,体阻塞和急性间歇性炎 (AIN).
研究的目的:
- 突出抗生素在药物诱导毒性中的作用.
- 讨论在重症患者中使用传统标记物的局限性,如肌素.
- 强调新型脏生物标志物的潜力,以早期检测和管理AKI.
主要方法:
- 对抗生素诱导的毒性机制的审查.
- 讨论临床表现,如急性管状亡 (ATN) 和AIN.
- 探索新的生物标志物,如囊素C和KIM-1.
主要成果:
- 抗生素可以通过各种途径诱导AKI,包括ATN和AIN.
- 像肌素这样的传统标志物在危急病患者中可能不可靠.
- 新型生物标志物对早期AKI检测和指导治疗决策充满希望.
结论:
- 新型生物标志物如囊素C和KIM-1可以促进早期检测抗生素诱导的AKI.
- 这些生物标志物可能有助于优化抗生素剂量和持续时间,从而可能预防毒性.
- 对非毒抗生素的进一步研究是有必要的.
更多相关视频
相关概念视频
Antibiotic Selection
54.2K
Overview
54.2K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Drug Elimination by Renal Route: Tubular Reabsorption
3.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K
Nephrons
2.5K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.5K

